end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndOtherAccruedLiabilitiesCurrent,AccountsPayableCurrent,AccountsReceivableNetCurrent,AccruedLiabilitiesCurrent,AccruedRentCurrent,AccruedRentNoncurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AvailableForSaleDebtSecuritiesAmortizedCostBasis,AvailableForSaleDebtSecuritiesGrossUnrealizedGain,AvailableForSaleDebtSecuritiesGrossUnrealizedLoss,AvailableForSaleSecuritiesDebtSecurities,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockDividendsPerShareCashPaid,CommonStockDividendsPerShareDeclared,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,CommonStockValueOutstanding,ComprehensiveIncomeNetOfTax,ContractWithCustomerLiabilityRevenueRecognized,DeferredIncomeTaxLiabilities,DeferredOfferingCosts,DeferredRentCredit,DeferredTaxAssetsGross,DeferredTaxAssetsInProcessResearchAndDevelopment,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseOther,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPrepaidExpenses,DefinedContributionPlanCostRecognized,Depreciation,EarningsPerShareBasic,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxSettlementsOther,EmployeeRelatedLiabilitiesCurrent,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,FairValueLiabilitiesLevel1ToLevel2TransfersAmount,FairValueLiabilitiesLevel2ToLevel1TransfersAmount,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3,FinancialLiabilitiesFairValueDisclosure,GeneralAndAdministrativeExpense,ImpairmentOfLongLivedAssetsToBeDisposedOf,IncentiveFromLessor,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeTaxExpenseBenefit,IncomeTaxesReceivable,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInDeferredLiabilities,IncreaseDecreaseInIncomeTaxesReceivable,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InvestmentIncomeInterest,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NumberOfOperatingSegments,NumberOfOperatingSegments,NumberOfReportableSegments,NumberOfReportableSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseExpense,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OtherAssetsNoncurrent,OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherLiabilitiesNoncurrent,OtherNonoperatingIncomeExpense,OtherSundryLiabilitiesNoncurrent,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquireShortTermInvestments,PreferredStockDividendsAndOtherAdjustments,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValueOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProceedsFromIssuanceOfPrivatePlacement,ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShortTermInvestments,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures,StockIssuedDuringPeriodValueShareBasedCompensation,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityParOrStatedValuePerShare,TemporaryEquitySharesAuthorized,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,TimeDepositsAtOrAboveFDICInsuranceLimit,UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic,UnrealizedGainLossOnInvestments,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,ValuationAllowanceDeferredTaxAssetChangeInAmount,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfSharesOutstandingBasic,DeferredTaxAssetsNet,IncreaseDecreaseInOperatingLeaseLiability,LeaseAndRentalExpense,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,OperatingLeaseWeightedAverageDiscountRatePercent,OtherPrepaidExpenseCurrent,PrepaidInsurance,PrepaidInterest,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,VariableLeaseCost
2020-06-30,2020-08-11,10-Q,"PLIANT THERAPEUTICS, INC.",PLRX,CIK0001746473,USD,2147000.0,2483000.0,3599000.0,9553000.0,30000.0,,2821000.0,-30000.0,398110000.0,786000.0,,786000.0,,328803000.0,324323000.0,273948000.0,,,273918000.0,,178461000.0,178461000.0,,7429999.0,,,0.0001,300000000.0,35427199.0,35427199.0,3000.0,,-17090000.0,,,,540000.0,,,,,,,,,,100000.0,300000.0,-1.39,-1.39,,,,,,,2003000.0,0.0,0.0,0.0,0.0,,,0.0,3040000.0,0.0,404000.0,,0.0,83000.0,,,,,,,,111000.0,10682000.0,,,2171000.0,2098000.0,2027000.0,996000.0,12987000.0,328803000.0,12036000.0,,,,-17001000.0,-17001000.0,,,,,20576000.0,-16976000.0,,8690000.0,2098000.0,1143000.0,2247000.0,2171000.0,1031000.0,451000.0,-89000.0,-89000.0,951000.0,-136000.0,7000.0,,,,,,,,,,8173000.0,,,,,,,,6850000.0,4029000.0,17536000.0,-82267000.0,3600000.0,,,134007000.0,315816000.0,,238293000.0,,1000.0,177000.0,0.0001,10000000.0,0.0,0.0,,,-89000.0,,,,12253943.0,12253943.0,,,,,,,,,,,,,,,,,
2020-09-30,2020-11-10,10-Q,"PLIANT THERAPEUTICS, INC.",PLRX,CIK0001746473,USD,1014000.0,3140000.0,7131000.0,7886000.0,13000.0,,3150000.0,-18000.0,399162000.0,1169000.0,123000.0,1169000.0,,312324000.0,307729000.0,273734000.0,,,273716000.0,,55224000.0,55224000.0,,7416476.0,,,0.0001,300000000.0,35465715.0,35465715.0,3000.0,,-16522000.0,,,,565000.0,,,,,,,,,,100000.0,300000.0,-0.47,-0.47,,,,,,,2889000.0,0.0,0.0,0.0,0.0,,,0.0,4591000.0,0.0,384000.0,,0.0,83000.0,,,,,,,,72000.0,,,,,,,,11978000.0,312324000.0,11026000.0,,,,-16534000.0,-16534000.0,,,,,21475000.0,-16661000.0,,,,,,,,451000.0,12000.0,12000.0,952000.0,55000.0,3000.0,,,,,,,,,,6515000.0,,,,,,,,7294000.0,4144000.0,16884000.0,-98801000.0,4814000.0,,,238776000.0,300346000.0,,,,3000.0,3000.0,0.0001,10000000.0,0.0,0.0,,,12000.0,,,,35445504.0,35445504.0,,,,,,,,,,,,,,,,,
2020-12-31,2021-03-16,10-K,"PLIANT THERAPEUTICS, INC.",PLRX,CIK0001746473,USD,1675000.0,2023000.0,9279000.0,9576000.0,85000.0,581000.0,3488000.0,-32000.0,400918000.0,3895000.0,,3895000.0,3124572.0,295526000.0,290754000.0,263729000.0,15000.0,47000.0,263697000.0,188000.0,50882000.0,50882000.0,-34925000.0,7338314.0,,,0.0001,300000000.0,35552795.0,35552795.0,3000.0,3000.0,-41564000.0,,682000.0,,581000.0,36123000.0,7617000.0,27047000.0,428000.0,474000.0,291000.0,266000.0,35441000.0,558000.0,400000.0,1310000.0,-1.95,-1.95,0.0,0.21,-0.326,-0.01,0.074,-0.001,4542000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17269000.0,0.0,283000.0,41500000.0,0.0,83000.0,922000.0,2227000.0,2689000.0,-17000.0,-250000.0,70000.0,2756000.0,478000.0,9687000.0,2027000.0,1144000.0,2247000.0,2171000.0,2098000.0,,12465000.0,295526000.0,11599000.0,213212000.0,-210866000.0,-37271000.0,-41533000.0,-41533000.0,1.0,,1.0,,83462000.0,-41645000.0,,,,,,,,451000.0,-31000.0,-31000.0,866000.0,-366000.0,2000.0,0.0,1532000.0,322605000.0,0.0,0.0001,10000000.0,0.0,0.0,0.0,4498000.0,150751000.0,,52019000.0,10000000.0,113271000.0,442000.0,-41533000.0,7809000.0,4321000.0,66193000.0,-117828000.0,41817000.0,3895000.0,0.0,226012000.0,283061000.0,0.1399,238294000.0,11000.0,11000.0,442000.0,,,,,250000.0,,-31000.0,2007000.0,513000.0,13512000.0,21344236.0,21344236.0,0.0,0.0,2500000.0,,,,0.0,0.0,,0.0,0.0,,90000.0,1459000.0,386000.0,0.0,
2021-03-31,2021-05-10,10-Q,"PLIANT THERAPEUTICS, INC.",PLRX,CIK0001746473,USD,965000.0,2886000.0,2174000.0,7364000.0,103000.0,571000.0,3847000.0,-18000.0,404868000.0,2578000.0,,2578000.0,4028727.0,275254000.0,270537000.0,243854000.0,20000.0,37000.0,243837000.0,,50819000.0,50819000.0,-63000.0,8908566.0,,,0.0001,300000000.0,35748336.0,35748336.0,3000.0,,-22842000.0,,,,,,,,,,,,,,200000.0,359000.0,-0.64,-0.64,0.0,,,,,,2300000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6566000.0,,,,,83000.0,665000.0,-7105000.0,-2092000.0,,0.0,0.0,-318000.0,,,,,,,,,11085000.0,275254000.0,10250000.0,1370000.0,12232000.0,-13665000.0,-22856000.0,-22856000.0,,,,,25093000.0,-22919000.0,,,,,,,,451000.0,14000.0,14000.0,835000.0,,1000.0,,242000.0,64806000.0,,,,,,,4180000.0,,,,,77280000.0,1370000.0,,8113000.0,4266000.0,18527000.0,-140684000.0,2174000.0,2578000.0,,213281000.0,264169000.0,,,,2000.0,1370000.0,,,,,,0.0,14000.0,,,,35645205.0,35645205.0,,,,,,,,,,,,,,,,,
2021-06-30,2021-08-09,10-Q,"PLIANT THERAPEUTICS, INC.",PLRX,CIK0001746473,USD,951000.0,2764000.0,1830000.0,8168000.0,120000.0,561000.0,4218000.0,-30000.0,407522000.0,2280000.0,,2280000.0,,255716000.0,250719000.0,233812000.0,,,233782000.0,,35193000.0,35192000.0,,8748133.0,,,0.0001,300000000.0,35853916.0,35853916.0,3000.0,,-22843000.0,,,,,,,,,,,,,,200000.0,400000.0,-0.64,-0.64,,,,,,,3069000.0,,,,,,,,5475000.0,,,,,83000.0,,,,,,,,,,,,,,,,11736000.0,255716000.0,10932000.0,,,,-22831000.0,-22831000.0,,,,,24693000.0,-22904000.0,,,,,,,,630000.0,-12000.0,-12000.0,804000.0,,0.0,,,,,,,,,,4825000.0,,,,,,,,8585000.0,4367000.0,19218000.0,-163515000.0,1789000.0,,,208788000.0,243980000.0,,,,2000.0,372000.0,,,,,,,,,,,35746922.0,35746922.0,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-09,10-Q,"PLIANT THERAPEUTICS, INC.",PLRX,CIK0001746473,USD,408000.0,2605000.0,1610000.0,10320000.0,138000.0,534000.0,4605000.0,-40000.0,411037000.0,2811000.0,,2811000.0,,234121000.0,228584000.0,203833000.0,,,203793000.0,,45231000.0,45231000.0,,8591311.0,,,0.0001,300000000.0,35977294.0,35977294.0,3000.0,,-27055000.0,,,,,,,,,,,,,,100000.0,400000.0,-0.75,-0.75,,,,,,,3787000.0,,,,,,,,7671000.0,,,,,83000.0,,,,,,,,,,,,,,,,13681000.0,234121000.0,12925000.0,,,,-27045000.0,-27045000.0,,,,,28723000.0,-27113000.0,,8174000.0,2098000.0,1143000.0,2247000.0,2171000.0,515000.0,831000.0,-10000.0,-10000.0,756000.0,,0.0,,,,,,,,,,5847000.0,,,,,,,,9311000.0,4706000.0,21052000.0,-190560000.0,1610000.0,,,175813000.0,220440000.0,,,,2000.0,702000.0,,,,,,,,,,,35906303.0,35906303.0,,,,,,,,,,,,,,,,,
2021-12-31,2022-03-01,10-K,"PLIANT THERAPEUTICS, INC.",PLRX,CIK0001746473,USD,907000.0,2971000.0,1998000.0,11991000.0,,,5019000.0,-201000.0,414348000.0,10437000.0,,10437000.0,3642021.0,221215000.0,209441000.0,183958000.0,1000.0,202000.0,183757000.0,57000.0,51665000.0,51665000.0,783000.0,8467491.0,0.0,,0.0001,300000000.0,36083301.0,36083301.0,,3000.0,-97432000.0,,2742000.0,,0.0,70426000.0,13989000.0,51554000.0,1816000.0,775000.0,292000.0,0.0,67684000.0,921000.0,600000.0,1535000.0,-2.71,-2.71,0.0,0.21,-0.332,-0.007,0.077,-0.001,5216000.0,0.0,,,,,,,27558000.0,0.0,0.0,-97300000.0,,83000.0,891000.0,-7281000.0,2695000.0,0.0,0.0,-70000.0,2266000.0,,8222000.0,2360000.0,0.0,1202000.0,2365000.0,2295000.0,,22156000.0,221215000.0,16831000.0,2527000.0,73699000.0,-75443000.0,-97263000.0,-97263000.0,,1.0,,1.0,105107000.0,-97535000.0,,,,,,,,838000.0,-169000.0,-169000.0,0.0,,0.0,457000.0,1953000.0,219887000.0,0.0,,,,,,6764000.0,0.0,,0.0,0.0,295539000.0,2984000.0,-97263000.0,9625000.0,4606000.0,77549000.0,-215091000.0,7572000.0,10437000.0,0.0,148931000.0,199059000.0,,,9000.0,,2984000.0,,,,,,,-169000.0,3505000.0,1081000.0,32243000.0,35846421.0,35846421.0,0.0,-1754000.0,,1028000.0,2300000.0,7194000.0,1869000.0,5325000.0,2400000.0,6330000.0,1669000.0,0.079,156000.0,2585000.0,385000.0,0.0,900000.0
